<![CDATA[Trial Assessing Savolitinib/Osimertinib in NSCLC Completes Enrollment]]> Cancer Network | November 5, 2025 Topics: lung-cancer, clinical-trials Read the full article at Cancer Network Back to Latest Cancer Research | Our Sources | Subscribe to Newsletter